{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:34:39Z","timestamp":1793388879364,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012352","name":"University of Milan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022087","name":"Illinois Nurses Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.virol.2025.110659","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:45:05Z","timestamp":1755495905000},"page":"110659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity"],"prefix":"10.1016","volume":"611","author":[{"given":"Alessandro","family":"Lucini Paioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Donnici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Nodari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Longo Minnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Alberico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Brindisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Mej\u00edas P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver T.","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca G.","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-7599","authenticated-orcid":false,"given":"Manuel","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110659_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nmeth.2327","article-title":"IGLuc: a luciferase-based inflammasome and protease activity reporter","volume":"10","author":"Bartok","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.virol.2025.110659_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2211688","article-title":"Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation","volume":"12","author":"Bei","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.virol.2025.110659_bib3","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2025.110659_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091339","article-title":"Recent advances in SARS-CoV-2 main protease inhibitors: from Nirmatrelvir to future perspectives","volume":"13","author":"Citarella","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.virol.2025.110659_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100181","article-title":"SARS-CoV-2 mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening","volume":"29","author":"Delgado","year":"2024","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.virol.2025.110659_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13100825","article-title":"Advances in the search for SARS-CoV-2 mpro and PLpro inhibitors","volume":"13","author":"Diogo","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2025.110659_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.77433","article-title":"Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms","volume":"11","author":"Flynn","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.virol.2025.110659_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01265-20","article-title":"Development of a fluorescence-based, high-throughput SARS-CoV-2 3CL pro reporter Assay","volume":"94","author":"Froggatt","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110659_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67468-7","article-title":"Rapid and sensitive large-scale screening of low affinity extracellular receptor protein interactions by using reaction induced inhibition of Gaussia Luciferase","volume":"10","author":"Galaway","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110659_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.cdd.4400497","article-title":"Purification and catalytic properties of human caspase family members","volume":"6","author":"Garcia-Calvo","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.virol.2025.110659_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.ado4288","article-title":"Discovery of SARS-CoV-2 papain-like protease (PLpro) inhibitors with efficacy in a murine infection model","volume":"10","author":"Garnsey","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virol.2025.110659_bib12","first-page":"1","article-title":"Emerging Sars-Cov-2 variants and impact in global vaccination programs against Sars-Cov-2\/Covid-19","volume":"9","author":"G\u00f3mez","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2025.110659_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.pathol.2020.09.006","article-title":"Laboratory biosafety measures involving SARS-CoV-2 and the classification as a risk group 3 biological agent","volume":"52","author":"Kaufer","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.virol.2025.110659_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jphotobiol.2018.04.050","article-title":"Bioluminescent and structural features of native folded Gaussia luciferase","volume":"183","author":"Larionova","year":"2018","journal-title":"J. Photochem. Photobiol., B"},{"key":"10.1016\/j.virol.2025.110659_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-025-56651-x","article-title":"Distal protein-protein interactions contribute to Nirmatrelvir resistance","volume":"16","author":"Lewandowski","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2025.110659_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2091-15-14","article-title":"Application of Gaussia luciferase in bicistronic and non-conventional secretion reporter constructs","volume":"15","author":"Luft","year":"2014","journal-title":"BMC Biochem."},{"issue":"49","key":"10.1016\/j.virol.2025.110659_bib17","doi-asserted-by":"crossref","first-page":"20697","DOI":"10.1021\/jacs.1c08060","article-title":"Discovery of Di- and trihaloacetamides as covalent SARS-CoV-2 main protease inhibitors with high target specificity","volume":"143","author":"Ma","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.virol.2025.110659_bib18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.apsb.2021.10.026","article-title":"Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and protease-glo luciferase assays","volume":"12","author":"Ma","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.virol.2025.110659_bib19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1134\/S0006297922120215","article-title":"Biology of the SARS-CoV-2 coronavirus","volume":"87","author":"Mingaleeva","year":"2022","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.virol.2025.110659_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03090-9","article-title":"Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay","volume":"5","author":"Narayanan","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.virol.2025.110659_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01715-20","article-title":"A versatile reporter system to monitor virus-infected cells and its application to Dengue virus and SARS-CoV-2","volume":"95","author":"Pahmeier","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110659_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.2002083","article-title":"A comprehensive review of SARS-CoV-2 vaccines: Pfizer, moderna & Johnson & Johnson","volume":"18","author":"Patel","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.virol.2025.110659_bib23","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s12010-015-1968-5","article-title":"Live cell reporter systems for positive-sense single strand RNA viruses","volume":"178","author":"Ren","year":"2016","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.virol.2025.110659_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12033-021-00299-7","article-title":"Cell-based high-throughput screening protocol for discovering antiviral inhibitors against SARS-COV-2 main protease (3CLpro)","volume":"63","author":"Rothan","year":"2021","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.virol.2025.110659_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2008.07.041","article-title":"Two forms of secreted and thermostable luciferases from the Marine copepod Crustacean, Metridia Pacifica","volume":"425","author":"Takenaka","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.virol.2025.110659_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102323","article-title":"FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 Mpro and PLpro","volume":"4","author":"Tan","year":"2023","journal-title":"STAR Protoc"},{"key":"10.1016\/j.virol.2025.110659_bib27","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.adm9724","article-title":"Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model","volume":"383","author":"Tan","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.virol.2025.110659_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nprot.2009.28","article-title":"Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo","volume":"4","author":"Tannous","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virol.2025.110659_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ymthe.2004.10.016","article-title":"Codon-optimized Gaussia luciferase CDNA for Mammalian gene expression in culture and in vivo","volume":"11","author":"Tannous","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2025.110659_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41586-021-03792-w","article-title":"After the pandemic: perspectives on the future trajectory of COVID-19","volume":"596","author":"Telenti","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110659_bib31","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041390","article-title":"The evolution and biology of SARS-CoV-2 variants","volume":"12","author":"Telenti","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.virol.2025.110659_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13080645","article-title":"Establishment of a luciferase-based reporter system to study aspects of human Cytomegalovirus infection, replication characteristics, and antiviral drug efficacy","volume":"13","author":"Tillmanns","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.virol.2025.110659_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2022.105252","article-title":"Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 omicron and other variants of concern","volume":"198","author":"Vangeel","year":"2022","journal-title":"Antiviral Res"},{"key":"10.1016\/j.virol.2025.110659_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-71305-6","article-title":"A Gaussia luciferase reporter assay for the evaluation of Coronavirus Nsp5\/3CLpro activity","volume":"14","author":"Vlachou","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110659_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2025.110659_bib36","article-title":"The development of an oral solution containing Nirmatrelvir and ritonavir and assessment of its pharmacokinetics and stability","volume":"16","author":"Wang","year":"2024","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.virol.2025.110659_bib37","first-page":"107","article-title":"Erratum: development of a laboratory-safe and low-cost detection protocol for SARS-CoV-2 of the coronavirus disease 2019 (COVID-19)","volume":"29","author":"Won","year":"2020","journal-title":"(Experimental Neurobiology"},{"key":"10.1016\/j.virol.2025.110659_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s13238-011-1034-1","article-title":"Activation and maturation of SARS-CoV main protease","volume":"2","author":"Xia","year":"2011","journal-title":"Protein Cell"},{"key":"10.1016\/j.virol.2025.110659_bib39","doi-asserted-by":"crossref","first-page":"8815","DOI":"10.1039\/D2CS00228K","article-title":"State-of-the-Art self-luminescence: a win-win situation","volume":"51","author":"Yang","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.virol.2025.110659_bib40","article-title":"Development of a luciferase-based biosensor to assess enterovirus 71 3C protease activity in living cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110659_bib41","article-title":"Improved fluorescence-based assay for rapid screening and evaluation of SARS-CoV-2 main protease inhibitors","volume":"96","author":"Zhang","year":"2024","journal-title":"J. Med. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225002727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225002727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:42:32Z","timestamp":1772808152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225002727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S0042682225002727"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110659","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110659"}}